-
Mashup Score: 112
Plasmablastic lymphoma (PBL) is an aggressive non-Hodgkin lymphoma associated with HIV infection and immunodeficiency. However, PBL can also be seen immunoco…
Source: www.frontiersin.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 112Multiple Auer Rod Like Inclusions in Multiple Myeloma - 6 day(s) ago
Indian Journal of Hematology and Blood Transfusion –
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24The future paradigm of HMA + VEN or targeted inhibitor approaches: sequencing or triplet combinations in AML therapy - 6 day(s) ago
Abstract. The routine use of next-generation sequencing methods has underscored the genetic and clonal heterogeneity of acute myeloid leukemia (AML), subsequent
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 51
Abstract. Treatment options for acute myeloid leukemia (AML) have expanded over the last 5 years. New regimens are increasing the options for patients who
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 40Improving long-term outcomes with intensive induction chemotherapy for patients with AML - 6 day(s) ago
Abstract. Intensive chemotherapy in combination with allogeneic hematopoietic cell transplantation and supportive care can induce long-term remissions in a
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 119
Non-inferiority of disease control could not be shown at the 2·5% significance level. The rate of treatment success was also not statistically better for patients with remission induction. Watchful waiting and immediate transplantation could be an alternative for fit patients with poor response or relapsed acute myeloid leukaemia who have a stem cell donor available. More randomised controlled intention-to-transplant trials are needed to define the optimal treatment before transplantation for patients with active acute myeloid leukaemia.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Thrombocytosis - 15 day(s) ago
An asymptomatic 55-year-old woman presented with thrombocytosis discovered 2 years earlier. Laboratory testing revealed the following: hemoglobin 13.1 g/dL, red blood cell count 5.04 × 10 9 /L, hematocrit 41.8%, mean corpuscular volume 83 fL, mean corpuscular hemoglobin concentration 31.3 g/dL, leukocytes 10.87 × 10 9 /L (neutrophils 43%, lymphocytes 45%, monocytes 5%, eosinophils 4%), and platelets 513 × 10 9 /L. Serum ferritin levels were low at 8 ng/mL. Physical examination was unremarkable. Serum
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22
Neoantigens arising from recurrent AML mutations are immunogenic and represent novel immunotherapeutic targets.IDH2R140Q-specific T cells can selectively e
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 77How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia - 15 day(s) ago
Using 4 illustrative cases, Treon and colleagues discuss their approach to therapy in patients with Waldenström macroglobulinemia (WM) based on genomic pro
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 31
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Hem/OncsTweet
Plasmablastic lymphoma: current knowledge and future directions https://t.co/1deWAyAJmp #lymsm https://t.co/5My0n4wf1v